The Patent Finder

Allos Therapeutics, Inc.

Also on record
Records under this name other than the patents Allos Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 8 of 8 · Back to Allos Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,847,120Compositions of Allosteric Hemoglobin Modifiers and Methods of Making the Same
Formerly held
Lapsed on the fee record
Ended Dec 7, 2018 · High confidence
Lapsed on the fee recordEnded Dec 7, 2018High confidence
US 7,097,825Methods and Reagents to Acquire MRI Signals and Images
Lapsed on the fee record
Ended Aug 29, 2014 · High confidence
Lapsed on the fee recordEnded Aug 29, 2014High confidence
US 6,214,879Allosteric inhibitors of pyruvate kinase
Formerly held
Lapsed on the fee record
Ended Apr 10, 2013 · USPTO record
Lapsed on the fee recordEnded Apr 10, 2013USPTO record
US 6,534,501Allosteric Inhibitors of Pyruvate Kinase
Formerly held
Lapsed on the fee record
Ended Mar 18, 2011 · Medium confidence
Lapsed on the fee recordEnded Mar 18, 2011Medium confidence
US 6,486,342Substituted chiral allosteric hemoglobin modifiers
Lapsed on the fee record
Ended Nov 26, 2010 · USPTO record
Lapsed on the fee recordEnded Nov 26, 2010USPTO record
US 5,525,630Treatment for carbon monoxide poisoning
Formerly held
Term ended
Term ended no later than Jun 11, 2016 · Low confidence
Term endedTerm ended no later than Jun 11, 2016Low confidence
US 5,677,330Medical uses of allosteric hemoglobin modifier compounds in patient care
Formerly held
Term ended
Term ended no later than Oct 14, 2017 · Low confidence
Term endedTerm ended no later than Oct 14, 2017Low confidence
US 5,927,283Allosteric modifiers of hemoglobin
Formerly held
Term ended
Term ended no later than Jul 27, 2019 · Low confidence
Term endedTerm ended no later than Jul 27, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited